HON vs. ANIP
HON (Honeywell International Inc) and ANIP (ANI Pharmaceuticals, Inc.) are both stocks. HON operates in Conglomerates (Industrials), while ANIP operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, HON returned 10.02%/yr vs 4.07%/yr for ANIP. At a 0.19 correlation, their price movements are largely independent.
Performance
HON vs. ANIP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HON achieves a 14.11% return, which is significantly higher than ANIP's 3.47% return. Over the past 10 years, HON has outperformed ANIP with an annualized return of 10.02%, while ANIP has yielded a comparatively lower 4.07% annualized return.
HON
- 1D
- 0.54%
- 1M
- 1.63%
- YTD
- 14.11%
- 6M
- 14.95%
- 1Y
- 5.66%
- 3Y*
- 7.43%
- 5Y*
- 2.86%
- 10Y*
- 10.02%
ANIP
- 1D
- 0.04%
- 1M
- 0.99%
- YTD
- 3.47%
- 6M
- 1.60%
- 1Y
- 31.49%
- 3Y*
- 18.03%
- 5Y*
- 18.57%
- 10Y*
- 4.07%
HON vs. ANIP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HON Honeywell International Inc | 14.11% | -6.37% | 10.02% | 0.02% | 4.90% | -0.29% | 22.97% | 36.70% | -8.27% | 35.10% |
ANIP ANI Pharmaceuticals, Inc. | 3.47% | 42.80% | 0.25% | 37.06% | -12.70% | 58.68% | -52.91% | 36.98% | -30.15% | 6.32% |
Correlation
The correlation between HON and ANIP is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since May 5, 2000 | 0.19 |
The correlation between HON and ANIP shifts across timeframes, from 0.12 (1 year) to 0.28 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
HON:
$140.65B
ANIP:
$1.76B
HON:
$6.42
ANIP:
$4.26
HON:
34.34
ANIP:
19.17
HON:
3.83
ANIP:
1.86
HON:
6.60
ANIP:
3.13
HON:
$36.76B
ANIP:
$923.71M
HON:
$13.58B
ANIP:
$486.11M
HON:
$6.55B
ANIP:
$234.71M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HON vs. ANIP — Risk / Return Rank
HON
ANIP
HON vs. ANIP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Honeywell International Inc (HON) and ANI Pharmaceuticals, Inc. (ANIP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HON | ANIP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.65 | ||
| Sortino ratioReturn per unit of downside risk | -1.16 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.19 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.34 | 1.10 | -0.76 |
| Martin ratioReturn relative to average drawdown | 0.59 | 2.06 | -1.47 |
Loading charts...
Drawdowns
HON vs. ANIP - Drawdown Comparison
The maximum HON drawdown since its inception was -70.09%, smaller than the maximum ANIP drawdown of -98.81%. Use the drawdown chart below to compare losses from any high point for HON and ANIP.
Loading charts...
Drawdown Indicators
| HON | ANIP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.09% | -98.81% | +28.72% |
Max Drawdown (1Y)Largest decline over 1 year | -16.54% | -28.66% | +12.12% |
Max Drawdown (3Y)Largest decline over 3 years | -22.10% | -28.66% | +6.56% |
Max Drawdown (5Y)Largest decline over 5 years | -27.13% | -59.38% | +32.25% |
Max Drawdown (10Y)Largest decline over 10 years | -43.01% | -72.96% | +29.95% |
Current DrawdownCurrent decline from peak | -10.69% | -81.85% | +71.16% |
Average DrawdownAverage peak-to-trough decline | -20.28% | -79.39% | +59.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.68% | 15.33% | -5.65% |
Volatility
HON vs. ANIP - Volatility Comparison
Honeywell International Inc (HON) has a higher volatility of 11.56% compared to ANI Pharmaceuticals, Inc. (ANIP) at 9.14%. This indicates that HON's price experiences larger fluctuations and is considered to be riskier than ANIP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HON | ANIP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.56% | 9.14% | +2.42% |
Volatility (6M)Calculated over the trailing 6-month period | 18.95% | 24.38% | -5.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.12% | 35.56% | -11.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.02% | 46.29% | -24.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.64% | 48.26% | -24.62% |
Dividends
HON vs. ANIP - Dividend Comparison
HON's dividend yield for the trailing twelve months is around 2.10%, while ANIP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ANIP ANI Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HON Honeywell International Inc | 2.10% | 2.25% | 1.93% | 1.99% | 1.85% | 1.81% | 1.71% | 1.90% | 2.24% | 1.79% | 2.11% | 2.07% |
Financials
HON vs. ANIP - Financials Comparison
This section allows you to compare key financial metrics between Honeywell International Inc and ANI Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HON vs. ANIP - Profitability Comparison
HON - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Honeywell International Inc reported a gross profit of 3.54B and revenue of 9.14B. Therefore, the gross margin over that period was 38.7%.
ANIP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 237.46M. Therefore, the gross margin over that period was 0.0%.
HON - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Honeywell International Inc reported an operating income of 886.00M and revenue of 9.14B, resulting in an operating margin of 9.7%.
ANIP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported an operating income of 38.89M and revenue of 237.46M, resulting in an operating margin of 16.4%.
HON - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Honeywell International Inc reported a net income of 821.00M and revenue of 9.14B, resulting in a net margin of 9.0%.
ANIP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported a net income of 29.49M and revenue of 237.46M, resulting in a net margin of 12.4%.
Frequently Asked Questions
HON and ANIP have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HON has higher volatility (11.56%) compared to ANIP (9.14%). In terms of maximum drawdown, HON dropped -70.09% vs ANIP's -98.81%.
ANIP currently has the higher Sharpe Ratio (0.89 vs 0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HON and ANIP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer